Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

This paper presents a power-efficient buffer-embedding successive approximation register (SAR) analog-to-digital converter (ADC) that utilizes a core power supply for the source-follower buffer, ...

Current source inverters (CSIs) featuring inherent short-circuit protection and no dv/dt issue are attracting increased attention in renewable systems. Existing single-phase 5-level CSIs have a ...